Today, China ranks second in the world, after the U.S., in terms of the number of publications, surpassing Germany, the UK, and Japan.
Chinese companies have progressively exhibited capability in R&D of innovative drugs and the number of investigational new drugs has noticeably risen, resulting in an increased number of new drugs being exported overseas.
Our latest report offers you exclusive insights into the Chinese pharma market trends and an in-depth analysis of the most successful and iconic cases.
What will you get from the report?
Get a clear understanding of the challenges and opportunities of the Chinese domestic market, of its need to innovate, and, at the same time, of the driving factors pushing the Chinese pharma companies to go global.
The report is structured per key aspects such as:
- Follow the trend of the times – Factors compelling firms to go international
- Insights on transactions – Trends on global expansion
- Early movers – In-depth analysis of typical cases
- Data-based decision-making – Application of data in screening overseas opportunities